Synchron Research Services Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 18-07-2024
- Paid Up Capital ₹ 6.49 M
as on 18-07-2024
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.43 Cr
as on 18-07-2024
- Satisfied Charges ₹ 5.51 Cr
as on 18-07-2024
- Revenue -99.24%
(FY 2023)
- Profit 8.72%
(FY 2023)
- Ebitda 59.01%
(FY 2023)
- Net Worth -256.08%
(FY 2023)
- Total Assets -55.31%
(FY 2023)
About Synchron Research Services
The Corporate was formerly known as Parexel International Synchron Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.49 M.
The company currently has active open charges totaling ₹3.43 Cr. The company has closed loans amounting to ₹5.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shivprakash Chinnappa and Urvashi Rathnam serve as directors at the Company.
- CIN/LLPIN
U85110GJ1998PTC034181
- Company No.
034181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Synchron Research Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivprakash Chinnappa  | Director | 26-May-1998 | Current |
| Urvashi Rathnam | Director | 07-Sep-1998 | Current |
Financial Performance of Synchron Research Services.
Synchron Research Services Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.24% decrease. The company also saw a slight improvement in profitability, with a 8.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 256.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synchron Research Services?
In 2023, Synchron Research Services had a promoter holding of 36.82% and a public holding of 63.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Intervein Laboratories Private LimitedActive 19 years 3 monthsShivprakash Chinnappa is a mutual person
Avance Phytotherapies Private LimitedActive 20 years 7 monthsShivprakash Chinnappa is a mutual person
Novelgenix Therapeutics Private LimitedActive 13 years 6 monthsShivprakash Chinnappa is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 25 Nov 2014 | ₹0.64 M | Open |
Corporation Bank Creation Date: 02 Apr 2003 | ₹3.37 Cr | Open |
Others Creation Date: 16 Apr 2021 | ₹3.30 Cr | Satisfied |
How Many Employees Work at Synchron Research Services?
Synchron Research Services has a workforce of 3 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synchron Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synchron Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
